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Background/aim: Prolonged hypercalcemia impairs renal function, and a reduced glomerular filtration rate (GFR) is typical in advanced
primary hyperparathyroidism (PHPT). There are scarce data related to predictors of renal impairment in patients with PHPT. Hence,
we aimed to evaluate changes in kidney function in PHPT patients after parathyroidectomy (PTX) and identify factors associated with
GFR variation in these patients.
Materials and methods: One hundred and twenty-five patients with PHPT who underwent surgery between 2012 and 2014 were
enrolled in the study. Patients were divided into two groups according to GFR values: patients whose GFR was lower than 60 mL/
min/1.73 m2 and higher than 60 mL/min/1.73 m2. Demographic and laboratory parameters were compared before and 6 months after
parathyroidectomy.
Results: Prevalence of antihypertensive drug users and patients with renal cysts and parathormone (PTH) and alkaline phosphatase
levels were higher in patients with GFR of ≥60 than in GFR of <60 mL/min/1.73 m2 (P < 0.05). Systolic BP, uric acid, and magnesium were
decreased in patients with GFR of ≥60, but GFR did not change in the two groups after parathyroidectomy. After parathyroidectomy,
calcium and PTH decreased but 25(OH)D3 and phosphorus increased in the two groups. In multiple regression analysis, age, calcium,
and baseline GFR were independent predictors of GFR variation. Parathyroid adenoma volume and urinary calcium were not
independent predictors of GFR change.
Conclusion: Older age, higher preoperative calcium, and GFR were factors associated with GFR increase in PHPT patients after
parathyroidectomy. Further renal impairment was prevented by parathyroidectomy in PHPT patients.
Key words: Primary hyperparathyroidism, predictors, renal failure, parathyroidectomy

1. Introduction
Primary hyperparathyroidism (PHPT), characterized by
overactivation of parathyroid glands causing excessive
release of parathyroid hormone, is a relatively common
endocrine disorder, with a prevalence of 1–7 cases per
1000 adults (1,2). Prolonged hypercalcemia impairs
renal function, and a reduced glomerular filtration rate
(GFR) is typical in advanced PHPT (3,4). Hypercalcemiainduced diuresis, nephrocalcinosis, and nephrolithiasis
are considered to be possible mechanisms causing
chronic kidney disease (CKD) in PHPT; however, the
exact pathogenesis is still unclear (4). Most studies
reported rates of the prevalence of CKD as approximately
16%–17% when an estimated glomerular filtration rate

(eGFR) cutoff below 60 mL/min per 1.73 m2 is taken into
consideration (5–7). Renal impairment is considered as
a surgical indication for PHPT (8,9) since surgery might
preserve renal function in these patients (9). However,
some studies showed no improvement in renal function
after parathyroidectomy (PTX) (3,4,10–12). Furthermore,
recent randomized controlled trials conducted primarily
with mild asymptomatic PHPT patients could not
demonstrate an improvement in renal function after PTX
(13–16). There are scarce data related to predictors of renal
impairment in patients with PHPT. Hence, we aimed to
evaluate changes in kidney function in PHPT patients after
PTX and identify factors associated with GFR variation in
these patients.
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2. Materials and methods
2.1. Patient selection
One hundred and twenty-five patients with PHPT who
underwent surgery in Dışkapı Teaching and Research
Hospital between 2012 and 2014 was enrolled in the study.
The study was approved by the Ethical Committee of Düzce
University (Date: 23.10.2017, No: 2017/139) and written
informed consent of participants was obtained before the
study. Patients with a complete medical history, serum
biochemistry and urinalysis results, ultrasonography of the
parathyroids and kidneys, and follow-up examination after
curative parathyroidectomy were included in the study.
Patients with multiple endocrine neoplasia, parathyroid
cancer, thyroid cancer, hyperparathyroidism-jaw tumor
syndrome, or interference with calcium and vitamin D
metabolism for at least 2 weeks before hospital admission
were excluded. PHPT was diagnosed by demonstrating
persistent hypercalcemia in the presence of inappropriately
normal or elevated PTH concentrations (8). Asymptomatic
primary hyperparathyroidism described patients who
lacked obvious signs and symptoms associated with either
elevated calcium or parathyroid hormone. The criteria for
surgery were in agreement with guidelines applied at the
time of the diagnosis (8). Six patients had double adenoma
and 119 patients had single adenoma.
Patients were divided into two groups according
to GFR values: patients whose GFR was lower than 60
mL/min/1.73 m2 and higher than 60 mL/min/1.73 m2.
Demographic and laboratory parameters were compared
before and 6 months after parathyroidectomy in both
groups. GFR variation is defined as the difference between
GFR levels at basal and 6 months after parathyroidectomy.
2.2. Clinical, biochemical, and hormonal measurements
Weight, height, circumferences of waist (WC) and hip
(HC), and systolic and diastolic blood pressure (BP) were
measured. All patients underwent a biochemical and
hormonal examination including serum glucose, albumin,
total calcium, phosphorus, creatinine, total cholesterol,
triglyceride, low-density lipoprotein cholesterol (LDL-C),
and high-density lipoprotein cholesterol (HDL-C) levels
the morning after an overnight fast, using colorimetric
methods. The concentration of plasma parathyroid
hormone (PTH) was measured using an intact PTH assay
(chemiluminescent immunoassay with an Immulite 2000;
normal range 12–65 pg/mL). Plasma 25-OH vitamin
D was measured via radioimmune assay. Vitamin D
deficiency was assessed by classifying serum 25(OH)D3
concentrations as follows: ≤ 10 ng/mL , severe; 11–20 ng/
mL, moderate; and 21–30 ng/mL, mild (17).
The CKD-EPI creatinine equation was used for
measurement of glomerular filtration rate as follows (18):
141 × min(Scr/κ,1)α × max(Scr/κ,1) × 1.209 × 0.993Age
× 1.018 [if female] × 1.159 [if black], where SCr is serum
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creatinine (in mg/dL), k is 0.7 for women and 0.9 for
males, α is –0.329 for women and –0.411 for males, min
is the minimum of SCr/k or 1, and max is the maximum
of SCr/k or 1.
Parathyroid ultrasonography (US) was performed
using high-resolution B-mode ultrasound images (EUB
7000 HV; Hitachi, Tokyo, Japan) with a 13-MHz linear
array transducer. The volume of parathyroid adenoma
was calculated by the ellipsoid model formula (length ×
thickness × width × 0.52) (19).
2.3. Statistical analysis
Statistical analysis was performed using SPSS 18.0 (SPSS
Inc., Chicago, IL, USA). Descriptive analyses were
expressed as mean ± standard deviation (SD), percentages
(%), and beta (β). Kolmogorov–Smirnov or Shapiro–Wilk
W tests were used for normality. Chi-square tests or Fisher
exact tests, where appropriate, were used for categorical
variables. The Student t-test for normally distributed
continuous variables and Mann–Whitney U test for
continuous variables that were not normally distributed
were used. The paired samples t-test for normally
distributed continuous variables and Wilcoxon test for
continuous variables that were not normally distributed
were analyzed before and after parathyroidectomy.
Multiple linear regression was used to examine factors
associated with GFR variations. P < 0.05 was considered
statistically significant.
3. Results
The mean age of PHPT patients was 53.93 ± 10.67 years.
Parathyroid adenoma volume was 1.17 ± 2.16 cm3 and
urinary calcium excretion was 394.49 ± 184.40 mmol/dL.
After parathyroidectomy, blood pressures, serum calcium,
uric acid, magnesium, PTH, and ALP decreased, but
25(OH)D3 and phosphorus increased in PHPT patients
(P < 0.05) (Table 1). Patients were divided into two groups
according to GFR values: patients with values lower than
60 mL/min/1.73 m2 and patients with values higher than 60
mL/min/1.73 m2. Mean age was higher in patients whose
GFR was <60 mL/min/1.73 m2 (66.12 ± 7.05 vs. 52.13 ±
9.93, P < 0.0001). Prevalences of patients with diabetes,
renal stones, and thiazide usage were similar between
groups (P > 0.05). BMI and blood pressures were similar in
the two groups. Prevalence of patients with hypertension
and renal cysts were higher in patients with GFR of
<60 mL/min/1.73 m2 (P < 0.05). PTH and ALP levels
were higher in patients with GFR of ≥60 than <60 mL/
min/1.73 m2 (P < 0.05) (Table 2). Systolic BP, uric acid, and
magnesium decreased in patients with GFR ≥60, but GFR
did not change in the two groups after parathyroidectomy.
After parathyroidectomy, serum calcium and PTH
decreased, but 25(OH)D3 and phosphorus increased in
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Table 1. Clinical and biochemical pre- and postparathyroidectomy parameters in PHPT patients.

BMI (kg/m2)

Preparathyroidectomy
(n = 125)

Postparathyroidectomy
(n = 125)

P

30.87 ± 5.22

31.06 ± 5.05

0.281

GFR (mL/min/1.73 m )

91.41 ± 18.76

94.25 ± 17.46

0.08

Creatinine (mg/dL)

0.78 ± 0.21

0.75 ± 0.21

0.08

25(OH)D3 (ng/mL)

16.20 ± 17.97

32.47 ± 17.43

<0.001

Calcium (mg/dL)

11.13 ± 0.75

9.44 ± 0.77

<0.001

Phosphorous (mg/dL)

2.63 ± 0.44

3.26 ± 0.49

<0.001

PTH (pg/mL)

216.50 ± 148.77

63.49 ± 27.16

<0.001

ALP

115.38 ± 50.57

85.21 ± 28.29

<0.001

UA

5.35 ± 1.40

5.03 ± 1.33

0.01

Mg

2.14 ± 0.21

2.07 ± 0.20

0.01

Glucose (mg/dL)

95.88 ± 20.58

96.42 ± 33.40

0.56

2

Data are represented as mean ± SD.
Table 2. Clinical preparathyroidectomy parameters in PHPT patients according to GFR.
GFR < 60 mL/min/1.73 m2
(n = 16)

GFR ≥ 60 mL/min/1.73 m2
(n = 109)

P

Age

66.12 ± 7.05

52.13 ± 9.93

<0.0001

Women, n (%)

12 (75)

94 (86)

0.27

Diabetics, n (%)

3 (23)

16 (14.6)

0.452

Hypertensives, n (%)

12 (75)

36 (33)

0.0014

Thiazide users, n (%)

2 (15)

22 (20)

0.672

Renal stones, n (%)

6 (40)

36 (33)

0.596

Renal cysts, n (%)

8 (53)

23 (22)

0.014

BMI (kg/m2)

32.67 ± 4.18

30.77 ± 5.33

0.11

Systolic BP (mmHg)

143.00 ± 16.76

137.68 ± 15.82

0.28

Diastolic BP (mmHg)

81.28 ± 7.68

84.52 ± 8.32

0.11

Creatinine (mg/dL)

1.17 ± 0.19

0.72 ± 0.14

<0.001

25(OH)D3 (ng/mL)

15.93 ± 12.55

16.23 ± 18.68

0.68

Calcium (mg/dL)

11.10 ± 0.60

11.13 ± 0.76

0.83

Phosphorous (mg/dL)

2.78 ± 0.45

2.60 ± 0.43

0.14

PTH (pg/mL)

154.38 ± 80.41

225.62 ± 154.46

0.01

ALP (U/L)

93.69 ± 31.70

118.56 ± 52.12

0.04

Uric acid (mg/dL)

7.30 ± 1.26

5.03 ± 1.14

<0.001

Mg (mg/dL)

2.03 ± 0.21

2.15 ± 0.21

0.08

Glucose (mg/dL)

96.80 ± 18.78

95.75 ± 20.90

0.96

Data are represented as mean ± SD.

the two groups (Table 3). In multiple regression analysis,
age, serum calcium, and baseline GFR were independent
predictors of GFR variation. Parathyroid adenoma volume

and urinary calcium were not independent predictors of
GFR change. Multiple regression analyses are shown in
Table 4.
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Table 3. Clinical pre- and postparathyroidectomy parameters of PHPT patients according to GFR.
GFR < 60 mL/min/1.73 m2 (n = 16)

BMI (kg/m )
2

GFR ≥ 60 mL/min/1.73 m2 (n = 109)

Pre-PTX

Post-PTX

P

Pre-PTX

Post-PTX

P

32.67 ± 4.18

32.70 ± 4.40

0.05

30.77 ± 5.33

30.90 ± 5.11

0.35

GFR (mL/min/1.73 m )

53.02 ± 5.94

58.42 ± 14.60

0.16

97.04 ± 12.20

98.53 ± 12.04

0.12

Creatinine (mg/dL)

1.1 ± 0.19

1.16 ± 0.31

0.56

0.72 ± 0.14

0.70 ± 0.13

0.10

2

25(OH)D3 (ng/mL)

15.9 ± 12.55

33.73 ± 15.52

0.001

16.23 ± 18.68

32.33 ± 17.69

<0.001

Calcium (mg/dL)

11.10 ± 0.60

9.43 ± 0.33

<0.001

11.13 ± 0.76

9.44 ± 0.48

<0.001

Phosphorous (mg/dL)

2.78 ± 0.45

3.36 ± 0.53

<0.001

2.60 ± 0.43

3.25 ± 0.49

<0.001

PTH (pg/mL)

154.38 ± 80.41

58.28 ± 20.80

0.001

225.62 ± 154.46

64.11 ± 27.83

<0.001

ALP

93.69 ± 31.59

76.27 ± 25.34

0.004

118.56 ± 52.12

86.11 ± 28.52

<0.001

UA

7.30 ± 1.26

6.89 ± 1.15

0.25

5.03 ± 1.14

4.78 ± 1.15

0.02

Mg

2.03 ± 0.21

2.11 ± 0.34

0.62

2.15 ± 0.21

2.07 ± 0.19

0.007

Glucose (mg/dL)

96.80 ± 18.78

87.63 ± 7.27

0.44

95.75 ± 20.90

97.31 ± 34.88

0.54

Table 4. Multiple linear regression model of independent
predictors of variation in eGFR before and after parathyroidectomy
in primary hyperparathyroidism (dependent variable = eGFR).
Independent variables

β

P-value

Parathyroid adenoma volume

0.041

0.66

Age (years)

0.436

<0.001

Baseline calcium (mg/dL)

–0.247

0.01

Baseline creatinine (mg/dL)

–0.001

0.99

Baseline GFR (mL/min/1.73 m2)

0.610

0.014

4. Discussion
The primary target for PHPT is the kidney. Impairment
of renal function is an indication for surgery because of
two concerns. The first concern is renal failure causing
the progression in hyperparathyroidism, in which the
mechanism can be explained by adding secondary
hyperparathyroidism to already existing PHPT. The
second concern is PHPT leading to deterioration in kidney
function via nephrolithiasis/nephrocalcinosis or direct
effects of serum calcium or PTH on renal function (9).
Mild untreated PHPT increases mortality and morbidity,
as seen in more severe PHPT (20). Current guidelines
recommend parathyroidectomy in PHPT patients if their
GFR is lower than 60 mL/min/1.73 m2 (8). The course of
renal function in PHPT patients with concomitant renal
disease remains controversial. Moreover, there is scarce
evidence in the literature about mild PHPT negatively
affecting renal function. A recent study demonstrated
that the guideline’s recommendations regarding PHPT
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had not been followed, and renal impairment predicted
against PTX in the study population (21). Tassone et
al. demonstrated that renal function decreased after
curative PTX in PHPT patients with GFR above 60 mL/
min/1.73 m2; however, curative PTX ceased further renal
impairment in PHPT patients with GFR lower than 60
mL/min/1.73 m2. Hence, they concluded that the decrease
in renal function might not be affected by PTX (22). Our
study shows that further renal impairment was prevented
in both of our groups and presurgical CKD-EPI eGFR
was significantly and independently associated with the
variation in GFR after PTX. This result might suggest
that parathyroidectomy can be recommended in PHPT
patients regardless of renal function.
Renal function was deteriorated by prolonged
hypercalcemia, and a reduced GFR is typical in advanced
PHPT (3,4). Walker et al. investigated whether the levels
of hypercalcemia and nephrolithiasis were associated with
worse renal function in patients with PHPT or not, and
they did not find that higher serum calcium or PTH or
nephrolithiasis were related to worse renal function (23).
In our present study, serum calcium was an independent
predictor of GFR variation. Yamashita et al. (24) reported
that the excised parathyroid weighed significantly more
in the renal insufficiency group than in the normal
renal function group. In our study, we could not find an
association between parathyroid adenoma volume and
renal function impairment.
Prevalence of patients with hypertension and renal
cysts was higher in patients with GFR lower than 60
mL/min/1.73 m2. These results might suggest that renal
damage as a result of PHPT may lead to hypertension and
renal cyst development.
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Starup-Linde et al. reported that urinary calcium
excretion was higher in PHPT patients with renal
calcification than in PHPT patients without (25). Cassibba
et al. (26) did not find a difference in total urinary
calcium excretion among those who did or did not form
kidney stones. Walker et al. (23) demonstrated a positive
relationship between eGFR and urinary calcium excretion.
Urinary calcium excretion was not an independent
predictor of renal function impairment in our study. There
are no data in the literature related to the change in urinary
calcium excretion after parathyroidectomy and its possible
role in affecting renal function deterioration in PHPT.
However, in our present study, we did not investigate
urinary calcium excretion after parathyroidectomy.
Although it is not statistically significant, there is an
increase in GFR in patients whose GFR is lower than 60

mL/min/1.73 m2. If we had more patients instead of only
16 patients in that group, it might have been possible
to reach a statistically significant conclusion. On the
other hand, more older patients and more patients with
lower calcium levels could also increase the possibility of
reaching statistically significance according to multiple
linear regression analysis.
In conclusion, our findings indicate that older
age, higher preoperative calcium, and GFR level were
factors associated with GFR increase in PHPT patients
after parathyroidectomy. Parathyroid adenoma volume
and urinary calcium excretion are not associated with
impairment of renal function. Further renal impairment
was prevented by parathyroidectomy in PHPT patients.
Moreover, parathyroidectomy might be recommended to
all PHPT patients regardless of renal function.
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